SW

Samuel Watson

BLS Pharmaceuticals Limited | Chief Executive Officer, Managing Director
Mr Watson since establishing BLS and the Dr Watson Brand in 2018, has become become player in the health and wellness industry in Europe, UK and Japan. In 2020. He is the CEO and founder of Breathe International Ltd.

Company and Roles

Company
Title
Tenure
Since
BLS
BLS
BLS Pharmaceuticals Limited
  • Chief Executive Officer
  • Managing Director
3yrs, 1mthMay 2023

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
BLS
BLS
BLS Pharmaceuticals Limited
19/03/2634,499,362635,801,384N/AN/A
BXN
BXN
19/03/2634,499,362635,801,384N/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
BLS
BLS
BLS Pharmaceuticals Limited
19/03/26
Buy
1,800,000$0.050$90,000On-market trade
BXN
BXN
19/03/26
Buy
1,800,000$0.050$90,000On-market trade
BLS
BLS
BLS Pharmaceuticals Limited
24/12/25
Issued
39,000,000$0.042$1,638,000Issue of securities
BLS
BLS
BLS Pharmaceuticals Limited
24/12/25
Issued
20,000,000$0.042$840,000Conversion of securities
BLS
BLS
BLS Pharmaceuticals Limited
24/12/25
Exercise
20,000,000$0.042$840,000Conversion of securities